COVID vaccine maker Novavax notes ‘substantial doubts’ about its future

Vaccine company Novavax, which makes the COVID-19 vaccine, says it has “significant doubts” about its ability to remain in business in the long term. Novavax says current cash flow projections should support near-term business, but “significant uncertainty” about earnings in 2023, U.S. government funding and ongoing arbitrations jeopardizes the company’s prospects for the future He […]